This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Effectiveness of Nirsevimab among Infants in their First RSV Season in the United States, October 2023–March 2024: A Test-Negative Design Analysis

Link
View Resource
Description
Analyzes the impact of the nirsevimab antibody for infants in their first respiratory syncytial virus (RSV) season. Utilizes 2023-2024 electronic health record (EHR) data from 6 healthcare systems to examine RSV-associated emergency department (ED) use and hospitalization according to patient demographics, social determinants of health, health conditions, and location on the rural-urban continuum.
Author(s)
Amanda B. Paynea, Steph Battan-Wraith, Elizabeth A.K. Rowley, et al.
Citation
The Lancet Regional Health - Americas, 49, 101196
Date
09/2025
Tagged as
Children and youth · Chronic respiratory conditions · Rural-urban differences · Specialty care · Statistics and data